Shoreline Biosciences Stock
Shoreline Biosciences is a biotechnology company harnessing the power of induced pluripotent stem cells (iPSCs) for the development of next-generation cell therapies. The company specializes in differentiation techniques, driving iPSCs into highly specific, mature cell types like macrophages and natural killer cells.
Management Team
| Kleanthis Xanthpoulos, Ph.D. Chairman and |
| Mauro Avanzi, MD, Ph.D. Chief Medical Officer |
| Charles Calderaro III CTO |
| Scott Forrest, Ph.D. Chief Business Officer |
| Robert Hollingsworth, Ph.D. Chief Scientific Officer |
| Vanessa Jacoby CFO |
